Page 769 - Coronavirus Vaccine

National capital accounts for 22.39% of India's corona deaths in 24 hours

131 of the 585 fatalities in the country were from Delhi

India Coronavirus Dispatch: Oxford vaccine may be a better fit for India

Delhi cemetary running out of space, 74 per cent Delhiites say they want markets shut, Covid immune response is enduring, may protect for decades-news on how the country is coping with the pandemic

Covid-19 Factoid: Maharashtra most affected, adds over 5,000 cases in a day

Delhi adds over 6,000 new cases for two days each, increases fine for not wearing facemasks in public to Rs 2,000.

World Coronavirus Dispatch: Rapid vaccine production the real challenge

Covid-19 shakes up world's most expensive cities, how four Canadian provinces have protected their people, Italy runs short of ICU staff and other pandemic-related news across the globe

Covid vaccine with no 'serious side-effects', but India faces cold-reality

Global drugmakers Pfizer and BioNTech have said that their Covid-19 vaccine was found 95 per cent effective in the final analysis of the Phase 3 trial, including in people aged over 65 years, paving the way for the companies to apply for emergency authorisation from US regulators within days. Based on current projections, the companies expect to produce globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses by the end of 2021. The major announcement comes just two days after leading biotechnology company Moderna said on Monday its virus vaccine had an efficacy rate of 94.5 per cent. But will the Pfizer vaccine be available in India? Watch the video >

India's economy may continue to face Covid-19 aftershocks till 2025: Report

HSBC Holdings Plc said India's potential growth could drop to 5% in the post-pandemic world from 6% on the eve of the outbreak and more than 7% before the global financial crisis

Record Covid-19 deaths in Delhi, Pfizer's '95% effective' vaccine, and more

With medical facilities under strain, as many as 45 doctors and 160 paramedics of the paramilitary forces have also arrived in the capital to serve the people

Maharashtra officials asked to ramp up testing ahead of 2nd Covid-19 wave

The Maharashtra government, anticipating a second wave of the infection, has asked authorities not to drop guard and take all necessary steps to deal with any situation

Pfizer-BioNTech's Covid-19 vaccine deliveries may start before Christmas

(Reuters) - Pfizer Inc and BioNTech <22UAy.DE> could secure emergency U.S. and European authorization for their COVID-19 vaccine next month after final trial results showed it had a 95% success rate and no serious side effects, the drugmakers said on Wednesday.

Jharkhand coronavirus update: 251 new cases, 3 fresh fatalities reported

Jharkhand's Covid-19 tally rose to 1,06,742 on Thursday as 251 more people tested positive for the infection

Global Covid-19 cases surpass 56 million-mark, says Johns Hopkins

The overall number of global coronavirus cases has surpassed the 56 million mark, while the deaths have surged to more than 1.34 million, according to the Johns Hopkins University

Pfizer, Moderna Covid-19 vaccines may be authorised for use within weeks

States and territories are prepared to begin distributing the vaccines within 24 hours of receiving regulatory authorization

Oil prices gain 2% on potential OPEC+ rethink and Covid-19 vaccine hopes

The market was also supported by a smaller-than-expected increase in U.S. crude stockpiles last week.

Pfizer-BioNTech vaccine deliveries could start 'before Christmas'

The success rate of the vaccine developed by U.S. firm Pfizer and Germany's BioNTech is the highest of any candidate in late-stage clinical trials so far, and experts said it was a significant achieve

Pfizer ends vaccine trial with 95% success rate, to apply for approval soon

Pfizer and BioNTech said they plan to submit the data to other regulatory agencies around the world.

Coronavirus LIVE: Delhi logs highest single-day fatality count; 7,486 cases

Coronavirus update: Maharashtra has 1,752,509 coronavirus cases, Karnataka 864,140, Andhra Pradesh 856,159, Tamil Nadu 761,568 and Kerala 533,500. Stay tuned for coronavirus India LIVE updates

Covid-19 vaccine unlikely before early or mid-2021: WHO Southeast Asia head

Even the front-runners among vaccine companies would take at least a few months to complete Phase-III trials and evaluate the efficacy and safety of individual vaccines

Wall Street edges higher on Covid-19 vaccine bets, Boeing approval

The S&P 500 rose 1.81 points, or 0.05%, to 3,611.34 shortly after the market opened

Pfizer, BioNTech plan regulatory filing as vaccine proves 95% effective

The companies said their vaccine protected people of all ages and ethnicities

Lockdown 2.0 in Delhi? Kejriwal's shut down plan as Covid rise fastest

Delhi Chief Minister Arvind Kejriwal has sought the Centre's nod for shutting down markets which could be Covid-19 hotspots. Authorities in the national capital have spelled out a fortified strategy including increasing ICU beds, doubling the testing capacity to 100,000 to 120,000 and deploying around 8000 surveillance teams in the wake of an alarming spike in cases. Kejriwal also said that the Delhi government has sent a proposal to Lt Governor Anil Baijal to allow only 50 people to attend wedding ceremonies against the earlier limit of 200. As the national capital has witnessed a spurt in coronavirus cases, people coming from Delhi to Noida will be randomly tested for Covid-19 from Wednesday.